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Cigarette smoking is a well-known risk factor for cardiovascular disease. Smoking can cause vascular endothelial dysfunction 
and consequently trigger haemostatic activation and thrombosis. However, the mechanism of how smoking promotes throm-
bosis is not fully understood. Thrombosis is associated with the imbalance of the coagulant system due to endothelial dysfunc-
tion. As a vital anticoagulation cofactor, thrombomodulin (TM) located on the endothelial cell surface is able to regulate intra-
vascular coagulation by binding to thrombin, and the binding results in thrombosis inhibition. This work focused on the effects 
of cigarette smoke extract (CSE) on TM-thrombin binding by atomic force microscopy (AFM) based single-molecule force 
spectroscopy. The results from both in vitro and live-cell experiments indicated that CSE could notably reduce the binding 
probability of TM and thrombin. This study provided a new approach and new evidence for studying the mechanism of 
thrombosis triggered by cigarette smoking. 
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Epidemiological and medical investigations have demon-
strated that exposure to cigarette smoking is an independent 
risk factor for cardiovascular disease [1,2], as it causes sig-
nificant endothelial dysfunction, an inflammatory state, and 
triggers coronary thrombosis [3–5]. Evidence from autopsy 
and clinical studies also showed that smoking is critical to 
arterial thrombosis via a direct toxic effect on the injured 
endothelium and endothelial cells, resulting in alterations of 
the haemostatic system and an increase in platelet reactivity 
which is relevant for the pathogenic effect of atherothrom-
bosis [6–8].  
To better understand the molecular mechanism of the in-
creased risk for chronic dysfunction from smoking, cigarette 
smoking extract (CSE) is widely used to mimic the tobacco 
dust environment induced by human smoking [9–11]. 
Edirisinghe et al. [12] found CSE impaired vascular endo-
thelial growth factor (VEGF-) and fluid shear stress (FSS-) 
mediated endothelial cell function, and had important cor-
relation with cardiovascular diseases associated with endo-
thelial dysfunction. Other studies showed that CSE could 
induce a dysfunction on fibrinolytic activity in human um-
bilical vein endothelial cells [13], and consequently a hy-
percoagulable state for thrombosis. Normal endothelium has 
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the ability for self-protection by generating a number of 
substances, including various antiagglutinating and antico-
agulant factors such as prostacyclin and thrombomodulin 
(TM) [14]. As a crucial anticoagulation cofactor, TM is 
constitutively expressed on the endothelial cell surface. TM 
can form a high affinity 1:1 complex with thrombin. The 
complex of thrombin/TM has several important roles in-
cluding activation of protein C and thrombin-activatable 
fibrinolysis inhibitor (TAFI), anti-inflammatory, and anti-
coagulation [15–17]. Whether CSE could affect throm-
bin/TM binding and induce intravascular thrombosis 
through the thrombin/TM pathway is as yet unclear.  
Atomic force microscopy (AFM) has been developed to 
be a powerful tool in the study of biomolecular interactions 
via single molecular force spectroscopy (SMFS) [18,19]. 
Encouraging results have been achieved on measuring the 
binding forces at the molecular level in buffer solution and 
near physiological conditions for protein/DNA, DNA/DNA, 
ligand/receptor and other biomolecule pairs [20–24]. These 
SMFS studies have offered valuable information for the 
investigation into the molecular basis for biomolecular 
recognition, cellular adhesion, and signal transduction. This 
method has also been successfully applied to study the ef-
fect of clinically drugs and drug candidates on the important 
biomolecular interactions [20,22,25].   
In this work, we applied AFM SMFS combined with flu-
orescence microscopy to study the effect of CSE on the in-
teraction of thrombin and TM in vitro and with living cells. 
The study adds to the understanding of CSE induction of 
thrombosis, showing that CSE inhibits thrombin/TM bind-
ing. For the first time the mechanism of action of CSE on 
thrombosis has been studied at the single molecular level.  
1  Materials and methods 
1.1  Materials 
Thrombin from human plasma, TM (human recombination), 
poly-D-lysine (Mw: 70000–150000), (3-Aminopropyl) tri-
ethoxysilane (APTES) and (3-Mercaptopropyl) trimethox-
ysilane (MPTMS) were all purchased from Sigma-Aldrich 
(Shanghai, China). The monoclonal antibody of TM was 
obtained from Abcam (Hong Kong, China). N-hydroxy- 
succinimide-polyethylene glycol-maleimide (NHS-PEG- 
MAL, Mw: 3400) was purchased from Laysan Bio (Arab, 
Alabama, USA). Vectors used in plasmid construction for 
pMD18t and pEGFP-N1 were purchased from TaKaRa 
(Dalian, China) and Invitrogen (New York, USA) respec-
tively. Lipofectamine was also obtained from Invitrogen. 
HEPES was obtained from Sino-American Biotech. (Los 
Angeles, USA). The reagents MEM and Opti-MEM were 
bought from Gibco, USA, while fetal bovine serum was 
purchased from Hyclone (Omaha, USA). Milli-Q purified 
water (18.2 MΩ) was used for all experiments. Other rea-
gents used in the experiments were all of analytical grade. 
1.2  Plasmid construction and cell culture 
The complete human TM cDNA fragment was amplified by 
RT-PCR using specific primers corresponding to the se-
quences (GenBank No. NM_000361.2; GenBank GI: 
40288292). Primers were 5′-CGAAGCTTATGCTTGGGG- 
TCCTGGTC-3′ (forward), and 5′-ATGGATCCGAGTCT- 
CTGCGGCGTCGC-3′ (reverse). 
The Hind III-digested positions were contained in all 
forward primers, whereas the BamH I-digested positions 
were contained in the reverse primers. After RT-PCR and 
restriction enzyme digestion, products were separated and 
purified, followed by their insertion into the pMD18t vector 
and then digested and inserted into the pEGFP-N1 vector 
with the same enzyme digestion. Construction of the plas-
mids was confirmed using sequencing.  
COS-7 cells were used in this study, and were cultured in 
35-mm tissue culture dishes with MEM, containing 10% 
fetal bovine serum in a humidified 5% CO2 atmosphere at 
37°C. Transient transfection was performed with lipofec-
tamine 2000 and 4 g mL1 plasmids (TM-GFP or 
pEGFP-N1) in Opti-MEM when cells were at 70%80% 
confluence. After 24 h incubation, the cells were washed 
twice with serum-free medium and the culture solution was 
changed to serum-free MEM containing 10 mmol L1 
HEPES for microscopy observation and force measurement. 
1.3  Cigarette smoke extract (CSE) preparation 
CSE was prepared using a previously reported method with 
slight modifications [26,27]. Two cigarettes (each contain-
ing 1.1 mg of nicotine, 13 mg of carbon monoxide and   
12 mg of tar) without filters, were smoked consecutively 
through a facility driven by a 50 mL injection syringe with a 
constant airflow. The smoke was bubbled through 50 mL 
phosphate buffered solution (PBS, 10 mmol L1 Na2HPO4, 
1.8 mmol L1 KH2PO4, 2.7 mmol L1 KCl, 140 mmol L1 
NaCl, pH=7.4) and controlled with a three-way cock, thus 
mimicking the gas fluid pathway during the smoking pro-
cess in the human lung. The obtained CSE solution was 
filtered through a 0.22-m filter to remove bacteria and 
large impurities. The pH of the CSE-PBS buffer was ad-
justed to a final value of 7.4. The concentration of this ob-
tained stock solution was defined as 100% CSE, and the 
solution was diluted in PBS buffer to a final concentration 
required in the experiment. The CSE solution was prepared 
immediately before each experiment. 
1.4  AFM tip preparation 
AFM silicon nitride (Si3N4) tips (NP-10, Veeco, Santa Bar-
bara, CA, USA) were used in all the experiments. Chemical 
modification of AFM tips for force measurement was car-
ried out according to previously reported procedures 
[20–24]. The cantilevers were placed in a plasma reactor 
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(PDC-32G-2, Harrick Scientific Co., NY, USA) to get clean 
and hydroxyl surfaces. The cleaned tips were incubated in a 
solution of 1.0% (v/v) MPTMS in toluene for 1 h, 1.0 mg 
mL1 NHS-PEG-MAL in DMSO for 2 h, and protein (e.g., 
thrombin) solution (2 g mL1 in PBS) for 0.5 h, sequen-
tially. After every reaction step, tips were washed using 
corresponding solvents sufficiently to remove all the 
un-reacted reagents. After final rinsing with PBS, the pro-
tein-modified tips were stored in PBS at 4°C until use. 
1.5  Silicon wafers preparation 
Single-crystal silicon wafers were cut into 1 cm×1 cm 
squares and modified with the protein TM-ECD as previ-
ously reported [21,23,24]. The wafers were first cleaned and 
hydroxized through treatment with chloroform, HF acid, 
alkaline solution (NH4OH/H2O2/H2O=1:1:5, v/v) in an ul-
trasonicator. Piranha solution (98% H2SO4/H2O2=7:3, v/v) 
was heated separately to 90°C to generate Si-OH groups. 
The cleaned wafers were transferred to a solution of 1.0% 
(v/v) APTES in toluene, incubated for 2 h at room tempera-
ture to obtain an amino surface, and then thoroughly and 
consequently rinsed with toluene, acetone and alcohol. Wa-
fers were then dried with nitrogen gas. The silanizing sili-
con wafers were transferred into TM-ECD solution (1 g 
mL1) for 3 h at room temperature, and then cleaned with 
PBS buffer, and kept at 4°C until use.  
1.6  Single-molecule force spectroscopy 
The measurement of force between the thrombin modified 
AFM tips and the TM-ECD modified silicon substrate or 
TM-GFP expressed on the living cells was carried out using 
PicoSPM with a PicoScan 3000 controller and a larger 
AFM scanner. The scanner was mounted on a fluorescence 
microscope (Olympus ×71, Japan). The fluorescence mi-
croscope was equipped with a mercury air lamp (OSRAM, 
Germany) and 10×/40× objectives. A U-MWIB2 filter set 
(Ex: BP 460–490 nm, Em: LP 510 nm, Olympus, Japan) 
was used for GFP imaging. The single molecule force spec-
trum was measured at the loading rate of 103104 pN s1 
with a soft cantilever (0.06 N m1). The calibrated spring 
constants of the protein modified tips were measured   
using the thermal noise method, ranging from 0.069 to     
0.078 N m1.  
2  Results and discussion 
2.1  Measurement of single-molecule binding force of 
thrombin-TM on silicon wafers 
We first measured the binding force of thrombin and TM in 
vitro using AFM single molecule force spectroscopy. With 
chemical modification, we coupled thrombin onto the AFM 
tips via a PEG linker (averaged length approximately 30 nm) 
and the extracellular domain of TM (TM-ECD) onto the 
silicon substrates. The PEG linker was used to keep the 
protein in a more flexible state and differentiate specific 
binding from nonspecific interaction [22,24]. The protein 
densities of both thrombin modified on tips and TM-ECD 
on silicon substrate were controlled to be low, so that only 
one pair of thrombin/TM-ECD molecules could be formed 
during the force measurement. The rupture forces of the 
complex of thrombin/TM-ECD were detected when the tip 
and silicon substrate were brought into and out of contact. 
Forces were measured with the same loading rates 103104 
pN s1. The representative force curves measured for 
thrombin/TM-ECD are shown in Figure 1A. The peak ap-
pearing around 2050 nm away from separation of the tip 
and substrate (Figure 1A(a)) was considered as the specific 
rupture of thrombin/TM-ECD, while peaks randomly seen 
after the separation point of the AFM tip and substrate were 
caused by nonspecific interaction (Figure 1A(b)). Figure 
1A(c) indicates that, when TM-ECD on the substrate was 
covered by binding with free TM antibody molecules, the 
specific peak for thrombin/TM-ECD disappeared.  
The force distribution histogram obtained from 1000 to 
1500 force curves is shown in Figure 1B. A single maxi-
mum in the histogram by Gaussian fitting indicated that the 
single-molecule forces were measured. The mean value of 
the most probable single molecular interaction force of 
thrombin/TM-ECD was determined as (45.3±1.4) pN (from 
three histograms obtained in three independent experiments). 
According to Poisson statistics, when the possibility of rup-
ture events is <30%, there are more than 85% probability of 
measuring forces between a single molecular pair [24]. As 
shown in Figure 1C, the binding probability of thrombin 
and TM-ECD was 22.8%±5.1%. This ensured that the forc-
es were mediated by a single pair of molecules. Blocking of 
the force with the TM monoclonal antibody TM-MAb solu-
tion was carried out to confirm that the measured forces 
were specific ones between thrombin and TM-ECD. When 
the binding was blocked with the TM-MAb solution, the 
binding probability decreased to 5.0%±2.3%, which was 
similar to the value when unmodified AFM tips and 
TM-ECD covered substrate were used.  
2.2  Effect of CSE on thrombin-TM binding on silicon 
substrate 
We then checked the effects of CSE on the binding of 
thrombin and TM-ECD. We added CSE solution into the 
PBS buffer to get a final concentration of 5% CSE and in-
cubated the silicon substrate in the above solution for 1 h. 
We noticed that the binding probability of thrombin and 
TM-ECD decreased to 7.3%±1.1%. When further blocking 
with TM-MAb, the binding probability was 4.7%±3.3% (as 
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Figure 1  Binding forces measured on silicon surface. A, Representative force curves obtained with thrombin (Thr)-modified AFM tips on silicon wafers 
covered by the thrombomodulin extracellular domain (TM-ECD), of which (a) displays a specific binding force of TM and thrombin, (b) shows a nonspecif-
ic interaction force between the AFM cantilever and silicon substrate, and (c) is a typical force curve after the system was blocked with TM monoclonal 
antibody (TM-MAb) solution. The solid arrows mark the rupture of Thr/TM-ECD. B, Histogram of binding forces of Thr/TM-ECD (bars, experimental data; 
solid line, theoretical Gaussian distribution curve). C, Binding probabilities of thrombin (Thr)-modified AFM tips on the silicon wafer surfaces covered by  
TM-ECD, and the binding probability of Thr and TM-ECD repressed by 5% CSE for 1 h. 
shown in Figure 1C). This result indicated that CSE admin-
istration indeed had effects on the interaction of thrombin 
and TM.  
To further determine the negative effects of CSE on the 
binding of thrombin and TM, we measured the forces with a 
gradient concentration of CSE for the same incubation time. 
To obviously show the different effects among different 
concentrations of CSE, we increased the modification den-
sity of TM-ECD on silicon surfaces to obtain a relatively 
high binding probability of Thr/TM-ECD (35.8%±2.5%, 
Figure 2A). After incubation with 0.05% CSE for 1 h, the 
binding probability decreased to 23.8%±1.7%. When the 
concentration of CSE increased to 0.5%, the binding proba-
bility decreased to 15.9%±0.8%, and a higher CSE concen-
tration of 5% led to a further decreased binding probability 
to 10.0%±2.0% (Figure 2A). This suggested that CSE ad-
ministration caused a lower binding probability for throm-
bin and TM-ECD binding, and the inhibition effect was 
CSE concentration dependent. 
When the concentration of CSE was 0.05%, the binding 
probability of thrombin and TM-ECD (23.8%±1.7%) was 
high enough to obtain statistical analysis of binding force, 
but still <30% to ensure single-molecule interaction events. 
From the force curves measured with 0.05% CSE, as shown 
in Figure 2B, the force distribution histogram displayed a 
single maximum of (43.8±0.4) pN by a Gaussian fit, which 
was similar to the value without CSE treatment ((45.3±1.4) 
pN, Figure 1B). It is interesting to discover that CSE did not 
affect the thrombin/TM binding force, instead it reduced the 
binding probability. 
2.3  Measurement of single-molecule force of TM- 
thrombin on living cells 
TM is a membrane protein, thus we further investigated 
interaction of TM and thrombin with living cells, where the 
environment is closer to physiological conditions. Thrombin 
was modified on the AFM cantilever and TM was expressed 
on the surface of living COS-7 cells as COS-7 cells have a 
low level of endogenous TM. EGFP was tagged to TM, 
therefore the COS-7 expressing TM-EGFP or EGFP could 
be observed using fluorescence microscopy, and the fluo-
rescence signal guided AFM tips to locate onto these cells 
for force measurements. 
Force measurements were performed using the same 
conditions as previous experiments on silicon surfaces. The 
protein densities of thrombin modified on tips and TM ex-
pressing on cells were also controlled to be low enough to 
allow binding of single pairs of molecules. Typical force 
curves are shown in Figure 3A(a) and (b) for thrombin/TM 
interaction. When occasionally more than one pair of spe-
cific binding occurred (Figure 3A(a)), only the last peak 
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Figure 2  Binding of Thr/TM-ECD repressed by CSE on silicon surface. A, Binding probabilities of thrombin (Thr)-modified AFM tips on the silicon 
wafers covered by TM-ECD with different conditions (incubation with different concentrations of CSE or TM-MAb ). B, Histogram of binding forces of  
Thr/TM-ECD incubation with 0.05% CSE for 1 h (bars, experimental data; solid line, theoretical Gaussian distribution curve). 
 
Figure 3  Binding forces measured on the living-cell surface. A, Representative force curves obtained with thrombin (Thr)-modified AFM tips on cells 
expressing TM-GFP (a and b), and after the system was blocked with TM-MAb solution (c). The solid arrows mark the rupture of Thr/TM. B, Histogram of 
binding forces of Thr/TM (bars, experimental data; solid line, theoretical Gaussian distribution curve). C, Binding probabilities of thrombin (Thr) modified  
tips on cells expressing different proteins under different conditions (with or without CSE). 
was collected for statistical calculation. Figure 3A(b) is a 
representative force curve of single molecular rupture force 
of thrombin/TM. Once the TM-MAb was added in the solu-
tion, no force peak could be detected (Figure 3A(c)). Simi-
lar to other reported force-distance curves on a soft sub-
strate, such as cells [22,28], the curves displayed a gradual 
decrease in the initial stage when the tip was retracted from 
the cell. The specific rupture forces appeared as the tip 
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moved for a distance of 0.13 m due to cell elasticity, 
which was very different from the curves obtained on rigid 
substrate, as shown in Figure 1.  
With 15002000 effective force curves obtained from 
several cells, we conducted statistical analysis into the 
binding force of thrombin/TM. The most probable single 
molecular interaction force of thrombin/TM is shown in 
Figure 3B. By averaging the mean values from the histo-
grams of three independent experiments, the single mole-
cule interaction force of thrombin/TM was determined as 
(60.9±0.8) pN. Several control experiments were performed. 
When blocking thrombin/TM with the TM-MAb, the spe-
cific rupture peak disappeared for the cells expressing TM, 
and the binding probability decreased markedly (from 
22.7%±3.9% to 4.1%±2.0%, as shown in Figure 3C). No 
interaction peak was observed with thrombin modified tip 
and the pEGFP-N1-transfected cells (without TM proteins), 
either before or after blocking with TM-MAb. A low bind-
ing probability of 4.7%±3.5% was observed. The low bind-
ing probabilities shown in the above control experiments 
were caused by non-specific interactions between the tip 
and cells. These results confirmed that forces detected with 
the thrombin modified AFM tip on cells expressing TM 
were due to specific interaction between thrombin and TM. 
It is worth noting that the force measured with living cells 
was larger than that on the silicon substrate. This finding 
may due to the different conformations of TM-ECD in vitro 
and on living cells. 
2.4  Effect of CSE on TM-thrombin binding on cells 
After measuring the interaction of thrombin and TM on 
living cells, we studied the effect of CSE on their binding. 
With 5% CSE administrated for 1 h, the binding probability 
of thrombin and TM obviously decreased to 5.4%±1.5% 
(Figure 3C). When the incubation time with 5% CSE expo-
sure prolonged to 6 h, the binding probability of thrombin 
and TM on living cell surface was unchanged compared 
with the probability at 1 h (5.4%±2.1% and 5.4%±1.5%, 
respectively, as shown in Figure 3C). This result indicated 
that CSE could disturb the binding of thrombin and TM, 
and the incubation time of 1 or 6 h did not further affect the 
binding of thrombin and TM induced by CSE.  
In the control experiment, we added the same concentra-
tion of CSE (5%) into cells expressing pEGFP-N1 and in-
cubated for 1 h. We then measured the binding of thrombin 
on AFM tips and cells by calculating 40005000 force 
curves from 67 cells. We found that either before or after 
blocking with TM-MAb, no obvious binding event was de-
tected between thrombin and the cells expressing EGFP 
only. The results from live cell experiments demonstrated 
that CSE indeed inhibits the binding of thrombin and TM. 
In summary, we have used AFM single molecular force 
spectroscopy combined with fluorescence microscopy to 
investigate the inhibition effects of CSE on thrombin/TM 
interaction both in vitro and with living cells. Our results 
demonstrated that CSE reduced the binding probability of 
thrombin to its specific receptor TM. This is the first time 
the interaction force of thrombin and thrombomodulin has 
been quantitatively assayed using AFM. The results provide 
new evidence for the understanding of thrombosis induced 
by smoking. As the CSE is a mixture of multiple compo-
nents, which components can be attributed to the inhibitory 
effect on thrombin/TM requires further investigation. 
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